Zobrazeno 1 - 10
of 38
pro vyhledávání: '"John W. Wilks"'
Publikováno v:
International Journal of Peptide and Protein Research. 21:127-134
The protected peptide, Ac-Glu(OBut)-D-Phe-D-Trp-Ser(But)-Tyr(But)-D-Lys (Z)-Leu-Arg(Tos)-Pro-Gly-NH2 was synthesized in a stepwise manner on a resin of poly-N-acrylylpyrrolidine using both acid cleavable N alpha-tert.-butyloxycarbonyl and base cleava
Autor:
Timothy G. Brayman, John W. Wilks
Publikováno v:
Antimicrobial Agents and Chemotherapy. 47:3305-3310
We implemented a simple, sensitive, objective, and rapid cellular assay to reveal the antifungal activity of a novel class of glucan synthase inhibitors. The assay, especially useful for early drug discovery, measures the transformation of Candida al
Autor:
E. Jon Jacobsen, Mark A. Mitchell, Susan K. Hendges, Kenneth L. Belonga, Louis L. Skaletzky, Lindsay S. Stelzer, Thomas. J. Lindberg, Edward L. Fritzen, Heinrich J. Schostarez, Theresa J. O'Sullivan, Linda L. Maggiora, Christopher W. Stuchly, Alice L. Laborde, Marc F. Kubicek, Roger A. Poorman, Joan M. Beck, Henry R. Miller, Gary L. Petzold, Pam S. Scott, Scott E. Truesdell, Tanya L. Wallace, John W. Wilks, Christopher Fisher, Linda V. Goodman, Paul S. Kaytes, Stephen R. Ledbetter, Elaine A. Powers, Gabriel Vogeli, John E. Mott, Catherine M. Trepod, Douglas J. Staples, Eric T. Baldwin, Barry C. Finzel
Publikováno v:
Journal of medicinal chemistry. 42(9)
The synthesis and enzyme inhibition data for a series of thiadiazole urea matrix metalloproteinase (MMP) inhibitors are described. A broad screening effort was utilized to identify several thiadiazoles which were weak inhibitors of stromelysin. Optim
Autor:
John W. Wilks, Mark A. Mitchell
Publisher Summary This chapter discusses the recent progress in identifying the key cellular and molecular features of angiogenesis and illustrates the recent novel compounds that have potential clinical utility. Among the in vivo assays, the chicken
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cadd5fda3b7d7ec687a4266e051a982e
https://doi.org/10.1016/s0065-7743(08)60413-3
https://doi.org/10.1016/s0065-7743(08)60413-3
Autor:
John W. Wilks
Publikováno v:
Prostaglandins. 13:161-170
The naturally-occurring metabolite of prostaglandin F2alpha, 15-keto prostaglandin F2alpha (15-keto PGF2alpha), elicited rapid and sustained declines in serum progesterone concentrations when administered to rhesus monkeys beginning on day 22 of norm
Autor:
Gere S. diZerega, John W. Wilks
Publikováno v:
Fertility and Sterility. 41:635-638
Monkeys received twice daily intramuscular injections of 3mg of purified porcine follicular fluid protein(s) for the first 14.5days of the menstrual cycle. Two of five treated monkeys had anovulatory menstrual cycles. Three monkeys had cycles charact
Autor:
John W. Wilks
Publikováno v:
Acta Endocrinologica. 97:569-572
Synthetic lysine-vasopressin (2 IU/kg body weight) terminated pregnancy in the rabbit when administered im on day 20, but not when administered on days 8 through 11 of gestation. Rabbits treated with vasopressin on day 20 delivered necrotic foetuses
Autor:
John W. Wilks, Norman A. Nelson
Publikováno v:
Prostaglandins. 28:323-332
Oral administration of 5-oxa-17-phenyl-18,19,20-trinor-PGF 1α methyl ester (PGF-analog) resulted in a consistent and dose-dependent inhibition of corpus luteum progesterone production in nonpregnant rhesus monkeys concomitantly treated with human ch
Autor:
John W. Wilks
Publikováno v:
Acta Endocrinologica. 106:538-543
This study was undertaken to determine if early follicular phase administration of a synthetic luteinizing hormone releasing hormone (LRH) agonist would produce luteal phase defects in the monkey. (D-His-(im-Bzl)6,Pro9]LRH n-ethylamide was administer
Publikováno v:
Endocrinology. 107:237-244
Blood samples were obtained frequently from stumptailed monkeys (Macaca arctoides) at midcycle and assayed for FSH, LH, 17 beta-estradiol, and progesterone. Periovulatory endocrine events were generally similar to those which have been described in r